Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial

SIMPLE SUMMARY: A large number of patients with head and neck squamous cell carcinoma (HNSCC) have an advanced-stage disease (stages III to IVB) that do not respond to therapy despite aggressive, site-specific multimodality therapy and most of them will develop disease recurrence. This is the descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Perri, Francesco, Longo, Francesco, Fusco, Roberta, D’Alessio, Valeria, Aversa, Corrado, Pavone, Ettore, Pontone, Monica, Marciano, Maria Luisa, Villano, Salvatore, Franco, Pierluigi, Togo, Giulia, Fazio, Gianluca Renato De, Ordano, Daniele, Maglitto, Fabio, Salzano, Giovanni, Maglione, Maria Grazia, Guida, Agostino, Ionna, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124504/
https://www.ncbi.nlm.nih.gov/pubmed/34064511
http://dx.doi.org/10.3390/cancers13092210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124504/
https://www.ncbi.nlm.nih.gov/pubmed/34064511
http://dx.doi.org/10.3390/cancers13092210

Ejemplares similares